VKTX · Viking Therapeutics, Inc. · Documents
Market Cap
$3.81B
Shares
116.65M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-29 | — | |
| 10-Q | 2026-07-29 | 2026-06-30 | |
| 8-K | 2026-05-26 | 2026-05-19 | |
| 10-Q | 2026-04-30 | 2026-03-31 | |
| 8-K | 2026-04-29 | — | |
| DEF 14A | 2026-04-01 | 2026-05-19 | |
| 8-K | 2026-02-11 | — | |
| 10-K | 2026-02-11 | 2025-12-31 | |
| 10-Q | 2025-10-23 | 2025-09-30 | |
| 8-K | 2025-10-22 | — | |
| 8-K | 2025-08-19 | — | |
| 8-K | 2025-07-23 | — | |
| 10-Q | 2025-07-23 | 2025-06-30 | |
| 8-K | 2025-05-27 | 2025-05-20 | |
| 10-Q | 2025-04-24 | 2025-03-31 | |
| 8-K | 2025-04-23 | 2025-04-18 | |
| 8-K | 2025-04-23 | — | |
| DEF 14A | 2025-04-08 | 2025-05-20 | |
| 8-K | 2025-03-11 | 2025-03-10 | |
| 10-K | 2025-02-26 | 2024-12-31 | |
| 8-K | 2025-02-05 | — | |
| 8-K | 2024-11-04 | — | |
| 10-Q | 2024-10-23 | 2024-09-30 | |
| 8-K | 2024-10-23 | — | |
| 10-Q | 2024-07-24 | 2024-06-30 | |
| 8-K | 2024-07-24 | — | |
| 8-K | 2024-06-04 | — | |
| 8-K | 2024-05-23 | 2024-05-21 | |
| 10-Q | 2024-04-25 | 2024-03-31 | |
| 8-K | 2024-04-24 | — | |
| DEF 14A | 2024-04-05 | 2024-05-21 | |
| 8-K | 2024-03-26 | — | |
| 8-K | 2024-03-04 | — | |
| 8-K | 2024-03-01 | 2024-02-28 | |
| 8-K | 2024-02-27 | — | |
| 10-K | 2024-02-07 | 2023-12-31 | |
| 8-K | 2024-02-07 | — | |
| 8-K | 2023-10-25 | — | |
| 10-Q | 2023-10-25 | 2023-09-30 | |
| 10-Q | 2023-07-26 | 2023-06-30 | |
| 8-K | 2023-07-26 | — | |
| 8-K | 2023-06-14 | 2023-06-13 | |
| 8-K | 2023-05-11 | 2023-05-09 | |
| DEF 14A | 2023-05-01 | 0001-01-01 | |
| 8-K | 2023-04-26 | — | |
| 10-Q | 2023-04-26 | 2023-03-31 | |
| 8-K | 2023-04-03 | — | |
| 8-K | 2023-03-31 | 2023-03-29 | |
| 8-K | 2023-03-28 | — | |
| 8-K | 2023-03-28 | — |
Showing 1–50 of 84 filings
Key facts
CIK
1607678
CUSIP
92686J106
13F (30d)
235 filings
234 filers
Visit website
Investor relations